Chimerism

Journal PubWeight™ 84.99‹?›

Top papers

Rank Title Year PubWeight™‹?›
1 Combined treatment with regulatory T cells and vascularized bone marrow transplantation creates mixed chimerism and induces donor-specific tolerance to vascularized composite allografts without cytoreductive conditioning. 2013 1.38
2 Cells from a vanished twin as a source of microchimerism 40 years later. 2010 0.97
3 Why are levels of maternal microchimerism higher in type 1 diabetes pancreas? 2010 0.94
4 Split chimerism between nucleated and red blood cells after bone marrow transplantation for haemoglobinopathies. 2011 0.90
5 Long-term feto-maternal microchimerism revisited: Microchimerism and tolerance in hematopoietic stem cell transplantation. 2016 0.89
6 Stem cell microchimerism and tolerance to non-inherited maternal antigens. 2016 0.89
7 Epigenetic approaches for the detection of fetal DNA in maternal plasma. 2016 0.89
8 Maternal and fetal microchimerism in granulocytes. 2016 0.89
9 At the crossroads between tolerance and aggression: Revisiting the "layered immune system" hypothesis. 2011 0.88
10 Male microchimerism in peripheral blood leukocytes from women with multiple sclerosis. 2011 0.86
11 Fetal microchimerism persists at high levels in c-kit stem cells in sensitized mothers. 2010 0.85
12 Can maternal microchimeric cells influence the fetal response toward self antigens? 2011 0.84
13 Parity and HLA alleles in risk of rheumatoid arthritis. 2011 0.83
14 Correlation between post transplant maternal microchimerism and tolerance across MHC barriers in mice. 2011 0.83
15 Cadaveric bone marrow as potential source of hematopoietic stem cells for transplantation. 2011 0.83
16 Quo vadis chimerism? 2011 0.83
17 Microchimerism and survival after breast and colon cancer diagnosis. 2012 0.83
18 Mixed chimerism and split tolerance: mechanisms and clinical correlations. 2012 0.83
19 Microchimeric fetal cells play a role in maternal wound healing after pregnancy. 2014 0.82
20 Validation of chimerism in pediatric recipients of allogeneic hematopoietic stem cell transplantation (HSCT) a comparison between two methods: real-time PCR (qPCR) vs. variable number tandem repeats PCR (VNTR PCR). 2012 0.82
21 Bidirectional alloreactivity: A proposed microchimerism-based solution to the NIMA paradox. 2012 0.82
22 Analysis of maternal microchimerism in rhesus monkeys (Macaca mulatta) using real-time quantitative PCR amplification of MHC polymorphisms. 2014 0.81
23 Fetomaternal microchimerism: Some answers and many new questions. 2011 0.81
24 Does microchimerism mediate kin conflicts? 2014 0.81
25 Double unit cord blood transplantation: Who wins-and why do we care? 2016 0.80
26 Maternal microchimerism in pediatric inflammatory bowel disease. 2011 0.80
27 Detection and quantification of chimerism by droplet digital PCR. 2013 0.80
28 DNA chimerism and its consequences after allogeneic hematopoietic cell transplantation. 2011 0.80
29 Naturally acquired microchimerism: implications for transplantation outcome and novel methodologies for detection. 2014 0.80
30 Predictors of male microchimerism. 2012 0.80
31 Major and minor histocompatibility antigens to NIMA: Prediction of a tolerogenic NIMA effect. 2011 0.80
32 Trogocytosis as a mechanistic link between chimerism and prenatal tolerance. 2013 0.80
33 The pendulum swings: Tolerance versus priming to NIMA. 2016 0.79
34 Pregnancy-induced maternal regulatory T cells, bona fide memory or maintenance by antigenic reminder from fetal cell microchimerism? 2014 0.79
35 We are all born as microchimera. 2012 0.79
36 The role of pDC, recipient T(reg) and donor T(reg) in HSC engraftment: Mechanisms of facilitation. 2011 0.79
37 Fetal microchimerism in skin wound healing. 2012 0.79
38 Regulation of the earliest immune response to in utero hematopoietic cellular transplantation. 2010 0.78
39 Microchimerism in women with recurrent miscarriage. 2015 0.78
40 The maternal immune response inhibits the success of in utero hematopoietic cell transplantation. 2011 0.78
41 Migration of microchimeric fetal cells into maternal circulation before placenta formation. 2010 0.78
42 Tolerance induction after organ transplantation, "delayed tolerance," via the mixed chimerism approach: planting flowers in a battle field. 2012 0.78
43 Maternal microchimerism: friend or foe in type 1 diabetes? 2014 0.77
44 Conditioning with α-emitter based radioimmunotherapy in canine allogeneic hematopoietic cell transplantation. 2012 0.77
45 Chimerism in transfusion medicine: the grandmother effect revisited. 2013 0.77
46 Safety of treatment with DLA-identical or unrelated mesenchymal stromal cells in DLA-identical canine bone marrow transplantation. 2013 0.77
47 Combining Treg therapy with mixed chimerism: Getting the best of both worlds. 2016 0.77
48 Transient mixed chimerism for allograft tolerance. 2015 0.77
49 Immigration control in the vertebrate body with special reference to chimerism. 2012 0.76
50 The health effects of fetal microchimerism can be modeled in companion dogs. 2013 0.76
Next 50